COVID-19 Pandemic and Cardiovascular Disease
There seems to be a unique interplay between 2019 novel coronavirus (SARS-CoV-2) and cardiovascular diseases, although it is predominantly a respiratory illness. Patients with pre-existing cardiovascular co-morbidities appear to be at highest risk for mortality from coronavirus disease 2019 (COVID-1...
Guardado en:
Autores principales: | Aniket S Rali, Andrew J Sauer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c98718393c414e089275941483f4123f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanisms of Myocardial Injury in Coronavirus Disease 2019
por: Aniket S Rali, et al.
Publicado: (2020) -
High-flow Nasal Cannula Oxygenation Revisited in COVID-19
por: Aniket S Rali, et al.
Publicado: (2020) -
Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
por: Aniket S Rali, et al.
Publicado: (2021) -
COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020) -
Excess mortality in Greece during 2020: the role of COVID-19 and cardiovascular disease
por: Demosthenes Panagiotakos, et al.
Publicado: (2021)